Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial

Published:2022-01 Issue:1 Volume:86 Page:77-85
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Stein Gold Linda,Papp Kim,Pariser David,Green Lawrence,Bhatia Neal,Sofen Howard,Albrecht Lorne,Gooderham Melinda,Chen Mindy,Paris Maria,Wang Yao,Callis Duffin Kristina

Funder

UCB

Eli Lilly and Company

Celgene

Amgen

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Dermatology

Reference21 articles.

1. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey;Lebwohl;J Am Acad Dermatol,2014

2. Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort;Egeberg;BMC Dermatol,2020

3. Assessing the impact of improvements in PASI and itch scores on patients' quality of life in the treatment of psoriasis;Yosipovitch;Acta Derm Venereol,2019

4. Topical treatments for chronic plaque psoriasis;Mason;Cochrane Database Sys Rev,2013

5. Topical therapies for psoriasis: improving management strategies and patient adherence;Stein Gold;Semin Cutan Med Surg,2016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of dermatologic drugs relevant to inflammatory bowel disease;JAAD Reviews;2024-09

2. Phosphodiesterase-4-Inhibitoren in der Dermatologie;Die Dermatologie;2024-08-30

3. Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway;Current Pharmaceutical Design;2024-07

4. Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study;Dermatology and Therapy;2024-06-19

5. Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT;Dermatology and Therapy;2024-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3